+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Autotransfusion Devices and Consumables Market by Product Type and End Use: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 4828566
  • Report
  • May 2019
  • Region: Global
  • 250 Pages
  • Allied Analytics LLP
Autotransfusion is a process of blood transfusion where the blood of the patient is extracted from the site of wound, which then gets filtered and purified. This blood is then infused back to the patients’ body. Autotransfusion is used in several surgeries such as cardiovascular surgery, orthopedic surgeries, surgeries related to trauma and during liver and other types of transplantation. The global autotransfusion devices and consumables market was valued at $864 million in 2018, and is estimated to reach $1,380 million by 2025, growing at a CAGR of 6.1% from 2019 to 2026.



The increase in the use of autotransfusion devices and consumables is due to its advantages over allogeneic techniques in preventing the risk of transfusion transmitted infection. In addition, the increase in the prevalence of cardiovascular diseases, trauma, transplantation and rise in technological advancements in blood transfusion techniques drive the autotransfusion devices and consumables market growth and is expected to follow the trend throughout the forecast period. Moreover, increase in government initiatives and focus on safe autotransfusion programs boosts the market growth. However, poor quality purification and improper mixing of blood components and a global shortage of autotransfusion can restrain the market growth. Furthermore, untapped market potential in developing regions is expected to provide lucrative opportunities for the market development.

This report segments the autotransfusions sales market based on product type, end use, and region to provide a detailed assessment of the market. Based on product type, it is bifurcated into devices and consumables. The devices segment is further categorized into on-pump transfusion devices and off-pump transfusion devices. Based on end use, the market is categorized into hospitals, ambulatory surgical devices, and others. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

North America is the highest contributor for the growth of autotransfusion devices and consumables market, owing to better healthcare infrastructure and technological advancement in the region along with high disposable incomes and preference over allogenic transfusion techniques by the healthcare professionals and patient population alike. North America is expected to continue this trend during the forecast period. Asia-Pacific is the fastest growing region for the autotransfusion devices and consumables market and is anticipated to remain dominant throughout the forecast period.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the autotransfusion devices and consumables market along with the current trends and future estimations to elucidate the imminent investment pockets.
A quantitative analysis from 2018 to 2026 is discussed to enable the stakeholders to capitalize on the prevailing market opportunities.
In-depth analysis of market based on product type such as devices and consumables are carried out in the report.
The global autotransfusion devices and consumables market scenario is comprehensively analyzed in accordance to the key cities.

KEY MARKET SEGMENTS

By Product Type
  • Devices
o On-pump Transfusion Devices
o Off-pump Transfusion Devices
  • Consumables

By End Use
  • Hospitals
  • Ambulatory Surgical Centres
  • Others

By Region
  • North America
o U.S.
o Canada
o Mexico
  • Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
  • Asia-Pacific
o Japan
o China
o Australia
o India
o Rest of Asia-Pacific
  • LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT (DEVICE PROVIDERS)

  • Becton, Dickinson and Company (C.R. Bard)
  • Brightwake Ltd.
  • Fresenius
  • Getinge AB
  • Haemonetics Corporation
  • LivaNova PLC
  • Medtronic Plc
  • Stryker
Frequently Asked Questions about the Global Autotransfusion Devices and Consumables Market

What is the estimated value of the Global Autotransfusion Devices and Consumables Market?

The Global Autotransfusion Devices and Consumables Market was estimated to be valued at $864.0 million in 2018.

What is the growth rate of the Global Autotransfusion Devices and Consumables Market?

The growth rate of the Global Autotransfusion Devices and Consumables Market is 6.9%, with an estimated value of $1380.0 million by 2025.

What is the forecasted size of the Global Autotransfusion Devices and Consumables Market?

The Global Autotransfusion Devices and Consumables Market is estimated to be worth $1380.0 million by 2025.
Note: Product cover images may vary from those shown

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Research methodology
1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings
2.1.1. Top investment pockets
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Parent Market Overview
3.3. Key Forces Shaping Autotransfusion devices and consumables market
3.3.1. Moderate bargaining power of suppliers
3.3.2. High bargaining power of buyers
3.3.3. High threat of new entrants
3.3.4. Moderate threat of substitutes
3.3.5. High intensity of rivalry
3.4. Pricing Analysis
3.4.1. Pricing Analysis, By Region, 2018 & 2025
3.5. Market evolution/Industry roadmap
3.6. Value Chain Analysis
3.7. Impact of government regulations on global autotransfusion devices and consumables market
3.8. Industry pain point analysis
3.9. Patent Analysis
3.9.1. By Region (2016-2018)
3.9.2. By Applicant
3.10. Market share analysis
3.11. Case Studies
3.11.1. Case Study
3.12. Market dynamics
3.12.1. Drivers
3.12.1.1. Technological advancement in the Autotransfusion system
3.12.1.2. Increased prevalence of Cardiovascular diseases
3.12.2. Restraints
3.12.2.1. Lack of skilled technicians for handling the Autotransfusion System
3.12.3. Opportunities
3.12.3.1. Increased adoption of Autotransfusion system
CHAPTER 4: AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Devices
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.2.4. On Pump Transfusion Devices
4.2.4.1. Key market trends and opportunities
4.2.4.2. Market size and forecast
4.2.4.3. Market analysis, by country
4.2.5. Off-Pump Transfusion Devices
4.2.5.1. Key market trends and opportunities
4.2.5.2. Market size and forecast
4.2.5.3. Market analysis, by country
4.3. Consumables
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.4. Market analysis, by country
CHAPTER 5: AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET, BY END USE
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Key market trends and opportunities
5.2.2. Market size and forecast
5.2.3. Market analysis, by country
5.3. Ambulatory Surgical Centers
5.3.1. Key market trends and opportunities
5.3.2. Market size and forecast
5.3.3. Market analysis, by country
5.4. Others
5.4.1. Key market trends and opportunities
5.4.2. Market size and forecast
5.4.3. Market analysis, by country
CHAPTER 6: AUTOTRANSFUSION DEVICES AND CONSUMABLES MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America market size and forecast, by Product type
6.2.3. North America market size and forecast, by end use
6.2.5. North America market size and forecast, by country
6.2.5.1. U.S. market size and forecast, by product type
6.2.5.2. U.S. market size and forecast, by end use
6.2.5.4. Canada market size and forecast, by product type
6.2.5.5. Canada market size and forecast, by end use
6.2.5.6. Mexico market size and forecast, by product type
6.2.5.7. Mexico market size and forecast, by end use
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe market size and forecast, by product type
6.3.3. Europe market size and forecast, by end use
6.3.4. Europe market size and forecast, by country
6.3.4.1. Germany market size and forecast, by product type
6.3.4.2. Germany market size and forecast, by end use
6.3.4.3. France market size and forecast, by product type
6.3.4.4. France market size and forecast, by end use
6.3.4.6. UK market size and forecast, by product type
6.3.4.7. UK market size and forecast, by end use
6.3.4.8. Italy market size and forecast, by product type
6.3.4.9. Italy market size and forecast, by end use
6.3.4.10. Spain market size and forecast, by product type
6.3.4.11. Spain market size and forecast, by end use
6.3.4.12. Rest of Europe market size and forecast, by product type
6.3.4.13. Rest of Europe market size and forecast, by end use
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific market size and forecast, by product type
6.4.3. Asia-Pacific market size and forecast, by end use
6.4.4. Asia-Pacific market size and forecast, by country
6.4.4.1. Japan market size and forecast, by product type
6.4.4.2. Japan market size and forecast, by end use
6.4.4.3. China market size and forecast, by product type
6.4.4.4. China market size and forecast, by end use
6.4.4.5. India market size and forecast, by product type
6.4.4.6. India market size and forecast, by end use
6.4.4.7. Australia market size and forecast, by product type
6.4.4.8. Australia market size and forecast, by end use
6.4.4.9. Rest of Asia-Pacific market size and forecast, by product type
6.4.4.10. Rest of Asia-Pacific market size and forecast, by end use
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA market size and forecast, by product type
6.5.3. LAMEA market size and forecast, by end use
6.5.4. LAMEA market size and forecast, by country
6.5.4.1. Brazil market size and forecast, by product type
6.5.4.2. Brazil market size and forecast, by end use
6.5.4.3. South Africa market size and forecast, by product type
6.5.4.4. South Africa market size and forecast, by end use
6.5.4.5. Rest of LAMEA market size and forecast, by product type
6.5.4.6. Rest of LAMEA market size and forecast, by end use
CHAPTER 7: COMPANY PROFILES
7.1. Becton, Dickinson and Company (C.R. Bard)
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. Brightwake Ltd.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segment
7.2.4. Product portfolio
7.3. Fresenius
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Getinge AB
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.5. Haemonetics Corporation
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. LivaNova PLC
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. Medtronic Plc.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. Stryker
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
Note: Product cover images may vary from those shown
According to this report titled,'Autotransfusion Devices and Consumables Market by Product Type and End Use: Global Opportunity Analysis and Industry Forecast, 2019 - 2026,'the global autotransfusion devices and consumables market size was valued to be at $864 million in 2018 and is expected to increase during the forecast period to be at $1,380 million by 2026, registering a CAGR of 6.1% from 2019 to 2026. The devices segment accounted for more than two-thirds of the total market share in 2018.

Autotransfusion is a method in which the blood is drained out from a patient’s body and is infused back after filtration and purification. It is performed in different ways—cell salvage, preoperative autologous donation, and acute normovolemic hemodilution or ANH. In cell salvage method, the blood is pumped out from the patient’s body and is infused back during the surgery. Cell salvage method can be further bifurcated into intraoperative and postoperative cell savage method. Preoperative autologous donation or PAD involves the donation of blood by a patient, which can be used by themselves in future. PAD involves is mostly used in hip replacement, hysterectomy, and total knee replacement surgeries. Acute normovolemic hemodilation is blood conservation techniques in which the blood from the patient is removed after inducing anesthesia while maintaining the normal volume of blood in the body using crystalloid or colloidal replacement.

The global autotransfusion devices and consumables market share has witnessed significant growth in the past few years. The growth in awareness regarding the lesser risk of transfusion transmitted infection. The rise in preference of autotransfusion techniques over allogeneic methods for blood transfusion amongst the healthcare professionals and patient population due to its higher efficiency and less risk of contamination contribute toward the market growth. In addition, government of developing countries such as India and China are promoting the use of autotransfusion techniques considering its lower morbidity and mortality rate due to infection, which is further expected to boost the autotransfusion devices and consumables market growth during the forecast period. However, higher cost and less affordability of autotransfusion devices as compared to allogeneic technique and stringent government regulations are projected to hamper the market growth during the forecast period. Conversely, untapped markets in the developing countries are expected to offer remunerative opportunities for the market players in the future.

Autotransfusion devices and consumables is a device used during various surgeries such as liver transplantation, hematopoietic stem cell transplantation, trauma due to injury, cardiovascular and orthopedic surgeries. Based on product type, autotransfusion devices include devices and consumables. The autotransfusion devices and consumables market growth has increased owing to increased prominence in the recent years due to high prevalence of cardiovascular surgeries worldwide and rise in number of cardiovascular diseases and transplantation cases.

Based on end use, the hospitals segment is the highest revenue contributor. Whereas, others segment is expected to exhibit fastest growth rate. This is attributed to the wider use of autotransfusion devices and consumables owing to its cost effectiveness.

Based on region, North America was the highest revenue contributor in the global autotransfusion devices and consumables market share, accounting for 60% of the total market in 2018. However, Asia-Pacific is expected to grow at the highest rate, owing to the number of developing nations present in this region, rise in technological advancements in the autotransfusion devices procured, increased awareness, and higher disposable income.

Key Findings of the Autotransfusion Devices and Consumables Market:

North America occupied more than one-third share of the global autotransfusion devices and consumables market in 2018.
The devices segment is the highest contributor in the product type segment.
The others in the end user segment is anticipated to grow with the highest CAGR throughout the forecast period.
The hospitals in the end use segment accounted for three-fourths share of the market in 2018.
The consumables segment is anticipated to grow with the highest rate in the product type segment throughout the forecast period.

This report provides a comprehensive analysis of the key payers operating in the global autotransfusion devices and consumables market. These include Becton, Dickinson and Company (C.R. Bard), Brightwake Ltd, Fresenius (Fresenius Kabi), Getinge AB, Haemonetics Corporation, LivaNova PLC, Medtronic Plc., and Stryker.
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...